Formulations for alteration of biophysical properties of mucosal lining

Abstract

Conductive formulations containing conductive agents, such as salts, ionic surfactants, or other substances that are in an ionized state or easily ionized in an aqueous or organic solvent environment, and methods of use, have been developed. One or more active agents, such as antivirals, antimicrobials, anti-inflammatories, proteins or peptides, may optionally be included with the formulation. The active agent may be administered with or incorporated into the formulation, or may be administered after the conductive formulation is administered. When applied to mucosal lining fluids, the formulation alters the physical properties such as the surface tension, surface elasticity, and bulk viscosity of the mucosal lining. The formulation is administered in an amount sufficient to alter biophysical properties in the mucosal linings of the body. The formulations may be administered for several different purposes: reducing the spreading of infectious diseases, both viral and bacterial, such as SARS, influenza, tuberculosis, and RSV in humans and hoof and mouth disease in cloven-tooted animals; minimizing ambient contamination due to particle formation during breathing, coughing, sneezing, or talking which is particularly important in the clean room applications; decreasing or preventing the occurrence of obstructive sleep apnea and some cases of irritable bowel syndrome; and controlling the uptake kinetics of drug molecules and pathogens.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application claims priority to U.S. Ser. No. 60 / 682,356, entitled “Formulations for Alteration of Biophysical Properties of Mucosal Lining”, filed May 18, 2005.FIELD OF THE INVENTION [0002] The present invention is in the field of formulations and methods to control particle shedding from mucosal surfaces, and alter uptake kinetics of drug molecules and pathogens. BACKGROUND OF THE INVENTION [0003] Many organs have a liquid mucosal lining whose biophysical properties can facilitate or impede normal function. A wide array of adverse health effects have been associated with the properties of a mucosal lining, for instance, particles ‘shed’ from the upper airway mucosal lining fluid (UAL) during normal exhalation may carry viable, infectious bacterial or viral pathogens, such as Severe Acute Respiratory Syndrome (“SARS”), influenza, tuberculosis, capable of spreading to healthy individuals through inhalation; the surface tension of th...

AI Technical Summary

Benefits of technology

[0015] Conductive formulations containing conductive agents, such as salts, ionic, surfactants, or other substances that are in an ionized state or easily ionized in an aqueous or organic solvent environment, and methods of use have been developed. One or more active agents, such as antivirals, antimicrobials, anti-inflammatories, proteins or peptides may optionally be included with the formulation. The active agent may be administered with or incorporated into the formulation or may be administered after the conductive formulation is administered. When applied to mucosal lining fluids, the formulation alters the physical properties such as the gel characteristics at the air / liquid interface, surface tension, surface viscosity, surface elasticity and bulk viscoelasticity of the mucosal lining. The formulation is administered in an amount sufficient to alter biophysical properties in the mucosal linings of the body. The formulations may be administered for several different purposes: reducing the spreading of infectious diseases, both viral and bacterial, such as SARS, influenza, tuberculosis, and RSV in humans and hoof and mouth disease in cloven-footed animals: relieving airway irritation and congestion due to respiratory conditions including acute infection (e.g. common cold), asthma, chronic bronchitis, emphysema, bronchiectasis, minimizing ambient contamination due to particle formation during breathing, coughing, sneezing, or talking which is particularly important in the clean room applications; decreasing or preventing the occurrence of obstructive sleep apnea and some cases of irritable bowel syndrome; and controlling the uptake kinetics of drug molecules and pathogens.

Problems solved by technology

Viral and bacterial infections are frequently highly contagious, especially when spread by respiration.

Other diseases such as influenza are spread by air contact, and rapidly reach epidemic proportions, with high numbers of fatalities in elderly and immunocompromised populations.

Multiple serotypes and numerous subtypes reduce the effectiveness and reliability of vaccines, The possible development of carriers in vaccinated animals and those that have recovered from FMD provides additional potential sources of new outbreaks.

Certain allergy medicines such as antihistamines as well as alcohol consumption can also relax the throat leading to OSA, Chronic OSA is observed in approximately 4% of the general population and leads to frequent waking and an increased work-of breathing throughout the night which can cause fatigue end sudden sleeping spells during normal activities.

However, many pathogens have developed sophisticated chemical transport systems to penetrate the mucosal layer, and in immunocompromised individuals the normal mechanisms for preventing pathogen uptake make be impaired or disabled.

A side-effect of the mucosal lining immune response is that beneficial drugs may be taken to be harmful by the body and blocked from passing through the mucosal lining.

Unfortunately, large amount of these substances have been found to be harmful to the mucosal membrane.

Images